These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 16611193)
1. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens. Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193 [TBL] [Abstract][Full Text] [Related]
2. [Follow-up diagnostics, referral and follow-up of hepatitis B and C patients]. Hofman R; Veldhuijzen IK; van der Lei J; Richardus JH Ned Tijdschr Geneeskd; 2018 Jan; 162():. PubMed ID: 30730118 [TBL] [Abstract][Full Text] [Related]
3. The disposition of hepatitis C antibody-positive patients in an urban hospital. Putka B; Mullen K; Birdi S; Merheb M J Viral Hepat; 2009 Nov; 16(11):814-21. PubMed ID: 19842281 [TBL] [Abstract][Full Text] [Related]
4. Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance. Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ramsay ME; J Viral Hepat; 2008 Oct; 15(10):729-39. PubMed ID: 18637078 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
6. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data. Bird SM; Goldberg DJ; Hutchinson SJ J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088 [TBL] [Abstract][Full Text] [Related]
7. Outcomes and costs of single-step hepatitis C testing in primary care, Birmingham, United Kingdom. Munang M; Smit E; Barnett T; Atherton C; Tahir M; Atabani SF Public Health; 2019 Jan; 166():40-44. PubMed ID: 30448691 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of a Hepatitis C screening program at a large urban VA medical center. Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298 [TBL] [Abstract][Full Text] [Related]
9. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014. Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D; MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252 [TBL] [Abstract][Full Text] [Related]
10. Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. Balogun MA; Laurichesse H; Ramsay ME; Sellwood J; Westmoreland D; Paver WK; Pugh SF; Zuckerman M; Pillay D; Wreghitt T Commun Dis Public Health; 2003 Apr; 6(1):34-9. PubMed ID: 12736970 [TBL] [Abstract][Full Text] [Related]
11. Medical care and alcohol use after testing hepatitis C antibody positive at STD clinic and HIV test site screening programs. Mark KE; Murray PJ; Callahan DB; Gunn RA Public Health Rep; 2007; 122(1):37-43. PubMed ID: 17236606 [TBL] [Abstract][Full Text] [Related]
12. Public Health Unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia. O'Brien ER; Whelan MC; Lama T; Levy M Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494075 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the patients with low levels of anti-HCV positivity]. Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. Yawn BP; Wollan P; Gazzuola L; Kim WR J Fam Pract; 2002 Feb; 51(2):135-40. PubMed ID: 11978211 [TBL] [Abstract][Full Text] [Related]
15. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups. Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142 [TBL] [Abstract][Full Text] [Related]
16. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients. Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus infection in children admitted to an urban hospital. Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408 [TBL] [Abstract][Full Text] [Related]
18. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976 [TBL] [Abstract][Full Text] [Related]
20. Outcome of screening for hepatitis C virus infection based on risk factors. Mallette C; Flynn MA; Promrat K Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]